AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Prospective CT Assessment After DCB

Recruitingn/aAges 19 Years - anyAllSeoul National University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This prospective, multicenter observational cohort study aims to investigate changes in target lesion hemodynamic parameters, diameter stenosis, plaque characteristics of CCTA before and after the DCB procedure and evaluate their association with clinical outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with Age โ‰ฅ 19 * Patients who took CCTA and were found to have coronary artery disease requiring reperfusion * Patients who underwent DCB within 3 months after CCTA and whose clinical presentation remained largely unchanged from the time of CCTA. * The target lesion is a de novo lesion with a vessel diameter between 2.25mm and 3.00mm * Patients deemed suitable for coronary intervention using drug-coated balloon by clinical assessment * Patients who have been adequately informed about this study and have voluntarily provided written consent to participate. Exclusion Criteria: * The target lesion is an in-stent restenosis lesion * Patient requiring emergency salvage stenting in target lesion * Patients with a stent previously implanted in the same vessel * Lesions involving chronic total occlusion or prior coronary artery bypass grafting (CABG). * Patients with eGFR (estimated glomerular filtration rate) \< 45 ml/min/1.73mm2 * Patients with coronary artery calcium score โ‰ฅ 1000 as determined by CCTA * Patients with an expected survival of less than 5 years * Pregnant or breastfeeding patients * Patients deemed inappropriate to participate in this study based on the judgment of study investigators
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Seoul National University Hospital
Seoul, South Korea
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy